BEAT - NASDAQ

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%

HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$50.63M

EPS-0.6200

P/E Ratio-3.85

Earnings Date05/07/2026

beat

Net Interest Income

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

HeartBeam, Inc. Competitors Analysis of Net Interest Income

BEAT · NASDAQ

Company	Net Interest Income	CAGR 3Y	CAGR 5Y	CAGR 10Y
HeartBeam, Inc. NASDAQ:BEAT	0.00	N/A	N/A	N/A
Equillium, Inc. NASDAQ:EQ	833.00K	-23.3%	N/A	N/A
Spruce Biosciences, Inc. NASDAQ:SPRB	-90.00K	N/A	N/A	N/A
Cue Biopharma, Inc. NASDAQ:CUE	450.00K	-31.8%	57.9%	N/A
TELA Bio, Inc. NASDAQ:TELA	-5.25M	N/A	N/A	N/A
Pulmonx Corporation NASDAQ:LUNG	-504.00K	N/A	N/A	N/A
MediciNova, Inc. NASDAQ:MNOV	1.30M	-10.8%	55.5%	N/A
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	-659.00K	N/A	N/A	N/A
MiNK Therapeutics, Inc. NASDAQ:INKT	180.25K	-27.0%	N/A	N/A
Werewolf Therapeutics, Inc. NASDAQ:HOWL	-2.17M	N/A	N/A	N/A
OS Therapies Incorporated NYSE:OSTX	-2.05M	N/A	N/A	N/A

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.47

Related Guides

Blog Categories

Continue your BEAT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.